(Q80573664)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

esophageal squamous cell carcinoma

1 January 2020

main subject

1 reference

inferred from title

squamous cell carcinoma

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Yoshio Ishibashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Tomoe Matsumoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Mikio Niwa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yutaka Suzuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nobuo Omura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nobuyoshi Hanyu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Koji Nakada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kyosuke Yamada

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kiyoshi Ohkawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Makio Kawakami

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Mitsuyoshi Urashima

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1994-2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

Moving disease biology from the lab to the clinic

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Incidence and prognostic significance of vascular and neural invasion in squamous cell carcinomas of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Vascular invasion of colorectal carcinoma readily visible with certain stains

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Prognostic significance of intramural metastasis in patients with esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Univariate and multivariate analyses of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Squamous carcinoma of the oesophagus: histological criteria and their prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the Europea

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20593

7 January 2021

Identifiers

DOI

10.1002/CNCR.20593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15372476%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference